Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion type Assertion NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_head.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion description "[Taken together, these data indicate that PDGFR?(+) pericytes may represent a novel, nonendothelial, antiangiogenic target for lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_provenance.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion evidence source_evidence_literature NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_provenance.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion SIO_000772 23632889 NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_provenance.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion wasDerivedFrom befree-2016 NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_provenance.
- NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_assertion wasGeneratedBy ECO_0000203 NP1073733.RAJyu5bNjMXsy8tWaSvSwALSxuw9KVB4CfdiKD_2hG3vM130_provenance.